Werewolf Therapeutics, Inc. is a highly innovative biotechnology company based in Watertown, MA, dedicated to transforming the landscape of cancer treatment. They develop novel cancer biotherapeutics, known as INDUKINE molecules, which enhance the body's immune response to cancer by selectively activating proinflammatory mechanisms within the tumor microenvironment, while minimizing off-target effects on non-target tissue.
With a team of experienced scientists and industry veterans, Werewolf Therapeutics combines expertise in oncology, immunology, and protein engineering to deliver effective cancer immunotherapies to the market. Their goal is to redefine cancer treatment and improve the lives of cancer patients through their targeted and transformative therapies.
Generated from the website